CJC-1295 & Ipamorelin — 10mg Vial

CJC-1295 & Ipamorelin 10mg Vial is a research-grade peptide combination supplied in a sterile lyophilized (freeze-dried) vial for laboratory and investigational use only. It combines two well-studied peptides: CJC-1295, a growth hormone-releasing hormone (GHRH) analog, and Ipamorelin, a selective growth hormone secretagogue (GHS).

In research settings, this combination is studied for its potential to stimulate pulsatile growth hormone release by acting on different regulatory pathways within the hypothalamic–pituitary axis. CJC-1295 is known for its extended half-life and sustained stimulation of GHRH receptors, while Ipamorelin selectively activates ghrelin receptors (GHS-R1a), promoting growth hormone secretion in experimental models without significant impact on cortisol or prolactin pathways in studies.

This product is not approved for human therapeutic use, prescription use, or over-the-counter consumption. It is intended strictly for controlled laboratory research purposes under appropriate regulatory compliance.

Each vial contains a total of 10mg of peptide blend (CJC-1295 + Ipamorelin) in a freeze-dried powder form and must be reconstituted before use in research environments.